To address whether IFN-γ-responsiveness of the tumor is required for lymphoma rejection, λ-hu-MYC mice were crossed onto syngeneic IFN-γ-receptor-deficient or STAT1-deficient mice. The gene discussed is STAT1; the disease is lymphoma.